Cetrorelix
Cetrorelix is luteinising hormone releasing hormone antagonist, which inhibits the release of gonadotrophins (luteinising hormone and follicle-stimulating hormone). It is used in the treatment of infertility by assisted reproductive techniques.
Primary Characteristics
It is of Synthetic origin.
Molecular Weight: 1431.06 · Non-proprietary name: Cetrorelix.

Pharmacokinetics
Absorption: Cetrorelix has an oral bioavailability is 42.5% (±42.5%).
Distribution: Cetrorelix has a plasma protein binding is 86%.
Elimination: plasma half-life is 60 hrs, renal excretion is faeces 5 -10% & urine 2-4%.
Advertisement
Indications
Cetrorelix is primarily indicated in conditions like Acute diarrhoea, Adjunct in the treatment of female infertilty (under specialist supervision).
Contraindications
Cetrorelix is contraindicated in conditions like Pregnancy, Breast feeding, Listerial meningitis (adjunct), Prophylaxis of gout.
Dosage
Cetrorelix's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 250 mcg | 250 mcg | — | SC | In tothe lower abdominal wall ,starting on day 5 or 6 of ovarian stimulation with gonadotophins (or each evening starting on day 5 of ovarian stimulation); continue throughout administration of gonadotrophin including day of ovulation induction. or 3mg on day 7 of ovarian stimulation with gonadotrophins;if ovulation induction is not possible on day 5 after 3mg dose,additional 250mcg once. |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Cetrorelix is known to cause more or less tolerable side effects which are usually transient. These include Headache, Hypersensitivity reactions, Injection site reactions, Nausea.
Warnings / Precautions
Available Brands
Storage Conditions
Drug Classification
- 1.18.2 — Androgens
Manufacturers
Manufacturers of Cetrorelix in Pakistan: